Use of Erlotinib in Patients Selected Using Clinical Criteria in the 2nd and 3rd Line Treatment of Non-Small Cell Lung Cancer (NSCLC)
Lung cancer（2009）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined